Publications by authors named "Gillian Bubb"

Claim this Profile
E
Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial.
Rossana Sanchez Russo, Serena Gasperini, Gillian Bubb, Linda Neuman, Leslie S Sloan

EClinicalMedicine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of arginase 1 deficiency and the unmet needs of patients: A systematic review of case reports.
Aseel Bin Sawad, Arti Pothukuchy, Mark Badeaux, Victoria Hodson, Gillian Bubb

JIMD Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency.
George A Diaz, Andreas Schulze, Markey C McNutt, Elisa Leão-Teles, J Lawrence Merritt, Gillian Bubb

J Inherit Metab Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB.
Chester B Whitley, Suresh Vijay, Bert Yao, Mercé Pineda, Geoff J M Parker, Gillian Bubb

Mol Genet Metab· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III.
Arunabha Ghosh, Elsa Shapiro, Stewart Rust, Kathleen Delaney, Samantha Parker, Gillian Bubb

Orphanet J Rare Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis